» Articles » PMID: 31893311

Eph Receptors: the Bridge Linking Host and Virus

Overview
Publisher Springer
Specialty Biology
Date 2020 Jan 2
PMID 31893311
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Eph (erythropoietin-producing hepatoma) receptors and Ephrin ligands constitute the largest subfamily of receptor tyrosine kinase (RTK), which were first discovered in tumors. Heretofore, Eph protein has been shown to be involved in various tumor biological behaviors including proliferation and progression. The occurrence of specific types of tumor is closely related to the virus infection. Virus entry is a complex process characterized by a series of events. The entry into target cells is an essential step for virus to cause diseases, which requires the fusion of the viral envelope and host cellular membrane mediated by viral glycoproteins and cellular receptors. Integrin molecules are well known as entry receptors for most herpes viruses. However, in recent years, Eph receptors and their Ephrin ligands have been reported to be involved in virus infections. The main mechanism may be the interaction between Eph receptors and conserved viral surface glycoprotein, such as the gH/gL or gB protein of the herpesviridae. This review focuses on the relationship between Eph receptor family and virus infection that summarize the processes of viruses such as EBV, KSHV, HCV, RRV, etc., infecting target cells through Eph receptors and activating its downstream signaling pathways resulting in malignancies. Finally, we discussed the perspectives to block virus infection, prevention, and treatment of viral-related tumors via Eph receptor family.

Citing Articles

The impact of epithelial-mesenchymal transition (EMT) induced by metabolic processes and intracellular signaling pathways on chemo-resistance, metastasis, and recurrence in solid tumors.

Liaghat M, Ferdousmakan S, Mortazavi S, Yahyazadeh S, Irani A, Banihashemi S Cell Commun Signal. 2024; 22(1):575.

PMID: 39623377 PMC: 11610171. DOI: 10.1186/s12964-024-01957-4.


Understanding the Cytomegalovirus Cyclin-Dependent Kinase Ortholog pUL97 as a Multifaceted Regulator and an Antiviral Drug Target.

Marschall M, Schutz M, Wild M, Socher E, Wangen C, Dhotre K Cells. 2024; 13(16.

PMID: 39195228 PMC: 11352327. DOI: 10.3390/cells13161338.


EphrinA5 regulates cell motility by modulating Snhg15/DNA triplex-dependent targeting of DNMT1 to the Ncam1 promoter.

Bora Yildiz C, Kundu T, Gehrmann J, Koesling J, Ravaei A, Wolff P Epigenetics Chromatin. 2023; 16(1):42.

PMID: 37880732 PMC: 10601256. DOI: 10.1186/s13072-023-00516-4.


EPHA2 Receptor as a Possible Therapeutic Target in Viral Infections.

Vincenzi M, Mercurio F, Leone M Curr Med Chem. 2023; 31(35):5670-5701.

PMID: 37828671 DOI: 10.2174/0109298673256638231003111234.


Out of the ESCPE room: Emerging roles of endosomal SNX-BARs in receptor transport and host-pathogen interaction.

Simonetti B, Daly J, Cullen P Traffic. 2023; 24(6):234-250.

PMID: 37089068 PMC: 10768393. DOI: 10.1111/tra.12885.


References
1.
Miao H, Wang B . EphA receptor signaling--complexity and emerging themes. Semin Cell Dev Biol. 2011; 23(1):16-25. PMC: 3374974. DOI: 10.1016/j.semcdb.2011.10.013. View

2.
Chesnokova L, Jiang R, Hutt-Fletcher L . Viral Entry. Curr Top Microbiol Immunol. 2015; 391:221-35. DOI: 10.1007/978-3-319-22834-1_7. View

3.
Zhuang G, Brantley-Sieders D, Vaught D, Yu J, Xie L, Wells S . Elevation of receptor tyrosine kinase EphA2 mediates resistance to trastuzumab therapy. Cancer Res. 2009; 70(1):299-308. PMC: 3859619. DOI: 10.1158/0008-5472.CAN-09-1845. View

4.
Peng Q, Chen L, Wu W, Wang J, Zheng X, Chen Z . EPH receptor A2 governs a feedback loop that activates Wnt/β-catenin signaling in gastric cancer. Cell Death Dis. 2018; 9(12):1146. PMC: 6242896. DOI: 10.1038/s41419-018-1164-y. View

5.
Gale N, Holland S, Valenzuela D, Flenniken A, Pan L, Ryan T . Eph receptors and ligands comprise two major specificity subclasses and are reciprocally compartmentalized during embryogenesis. Neuron. 1996; 17(1):9-19. DOI: 10.1016/s0896-6273(00)80276-7. View